Closed Loop Medicine

Activities: Training & Education Regulatory

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Dosage Forms

Closed Loop Medicine launches WeDosify, the first personalised GLP-1 dosing platform in the US

Backed by 29 studies and over 15,000 patient profiles, the platform delivers personalised dosing recommendations to reduce side effects and help clinicians keep patients on therapy for longer
Digital

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Paul will work with the company to drive forward its commercialisation strategy for its portfolio of precision care solutions
Research & Development

Closed Loop Medicine & Pharmanovia's OptiZest study for precision hypertension therapeutic commences

The study will investigate the efficacy of at-home, personalised dose management with Zestril for the treatment of hypertension
Research & Development

Teva UK and Closed Loop Medicine partner to advance personalised medicine development

SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Regulatory

First-line anti-hypertensive drug and software partnership

Hypertension is the leading preventable cause of morbidity and premature death worldwide, impacting over 1 in 4 men and 1 in 5 women, and costing the NHS alone over £2.1 billion/year
Subscribe now